In psoriasis, these agents have been associated with significant reductions in Psoriasis Area and Severity Index (PASI) scores, independent of weight loss, by reducing cytokine expression (e.g., TNF-α) and potentially regulating immune cell activity, including peripheral regulatory T-cells [4]. The gene discussed is TNF; the disease is psoriasis.